T obacco smoking is one of the most important risk factors for intracranial aneurysm formation and for an aneurysmal subarachnoid hemorrhage (aSAH). 2, [6] [7] [8] [9] 12, 13 Previous studies have shown that smoking cigarettes increases the risk for an aSAH up to 6-fold when compared with the risk in the general population.
term outcomes after endovascular embolization of intracranial aneurysms, we studied these outcomes among a consecutive contemporary series of patients treated at our institution. The goal of this study was to determine whether smoking is an independent risk factor for aneurysm recurrence and retreatment after endovascular treatment. We hypothesized that endovascular treatments of aneurysms would result in a higher rate of aneurysm recurrence, retreatment, or of both among patients who smoked or had a history of smoking than among patients who never smoked.
Methods

Patients and study Design
After receiving approval from the internal review board, we conducted a retrospective chart review of all patients who had received endovascular treatment of intracranial aneurysms from January 2005 through December 2012. The inclusion criteria in this study were that patients had received intrasaccular coil embolization of an intracranial aneurysm, had undergone a follow-up imaging exam at least 6 months later, and had a record of a smoking history. Patients who had undergone a planned and staged multisession embolization were excluded. A retreatment was considered planned and staged if the treating team mentioned in the operative note or followup clinical notes that further treatment was recommended to improve aneurysm occlusion. All patients underwent at least 1 follow-up digital subtraction angiography exam or MR angiography exam.
Once the patients were selected, their data were collected, including demographic characteristics (sex, age, and smoking history), aneurysm characteristics (rupture status, maximum diameter, and location), treatment characteristics (type of treatment and retreatment), initial aneurysm occlusion, use of adjunctive devices such as a stent or balloon, length of follow-up, and any aneurysm occlusion at follow-up.
Smoking status was determined from each patient's medical history questionnaire obtained before or during the treatment. The questionnaire asked the following questions: 1) "Do you currently smoke?" and 2) "Have you ever smoked? If so, how long ago did you quit smoking?" Smoking status was then stratified into 3 groups: 1) never a smoker, 2) current smoker (smoked at the time of treatment), and 3) former smoker (quit smoking before treatment). The 2 primary outcomes of this study were aneurysm recurrence and aneurysm retreatment after an endovascular aneurysm treatment. Initial aneurysm occlusion was categorized according to the Raymond scale into the following: 1) residual aneurysm, 2) residual neck, and 3) complete occlusion. Follow-up aneurysm occlusion status was categorized into the following 2 outcomes: 1) stable occlusion and 2) aneurysm recurrence defined as coil compaction, recanalization, or both.
statistical analysis
Continuous variables are presented as mean ± SD and categorical variables as frequency (as percentage). Kruskal-Wallis and chi-square tests were used to test statistical significance in aneurysm recurrence or retreatment according to differences in patient characteristics. A univariate logistic regression analysis was performed to test for an association of the primary outcomes, aneurysm recurrence or retreatment, with age, sex, smoking status, aneurysm characteristics (rupture status, initial occlusion, location, and maximum diameter), adjunctive device usage, and length of follow-up. A multivariate logistic regression analysis was then performed, adjusting for the differences in the patient groups with primary outcomes as the dependent variable and smoking status and variables that were significant at the univariate level as the independent variables. All statistical analysis was performed using SAS version 9.3.
results
Patient and aneurysm characteristics
In this study, 384 patients who had a combined total of 411 aneurysms were included. Thirty-nine patients with a combined total of 44 aneurysms treated with flow diversion and 5 patients with 1 aneurysm each who underwent a planned, staged treatment were excluded from this study. Of the patients included, 23 had 2 treated aneurysms, and 2 patients had 3 treated aneurysms. Overall, 106 patients with 111 aneurysms (27.0%) had recurrence of an aneurysm, and of these patients, 78 with 80 aneurysms (19.5%) underwent retreatment for the aneurysm. In the remaining patients with recurrent aneurysms, the recurrence was not considered of clinical significance and observation only was recommended.
The demographics, main aneurysm characteristics, and immediate angiographic results for the 3 patient groups are summarized in Table 1 . The mean age of all patients was 61 ± 12.2 years, and the mean length of follow-up was 2.4 ± 2.3 years. An analysis by smoking status showed that 172 patients with 193 aneurysms (47.0%) were current smokers, 95 patients with 99 aneurysms (24.1%) were former smokers, and 117 patients with 119 aneurysms (29.0%) were never smokers. In total, 272 treated aneurysms (66.2%) were unruptured and 139 (33.8%) were ruptured, and the mean diameter of all aneurysms was 7.5 ± 4.3 mm. In total, 186 aneurysms (45.3%) were completely occluded on initial treatment, 185 (45.0%) had a residual neck, and 40 (9.7%) had a residual aneurysm and were not occluded. In a subset of 94 aneurysms (22.9%), an adjunctive device was used, with 93 of these aneurysms (98.9%) receiving balloon-assisted coiling and 1 aneurysm (1.1%) receiving stent-assisted coiling.
With a mean age of 65.2 ± 11.3 years, former smokers were significantly older than those who were never smokers (61.1 ± 14.4 years) and were current smokers (58.5 ± 10.3 years) (p < 0.001). The aneurysm diameter was not significantly different among the groups (p = 0.35), with mean diameters of 7.8 ± 5.2 mm for those who were never smokers, 7.6 ± 3.5 mm for those who were former smokers, and 7.3 ± 3.9 mm for those who were current smokers. The 3 groups differed in the proportion of those having ruptured aneurysms: 37.8% of current smokers (73 aneurysms), 36.1% who were never smokers (43 aneurysms), and 23.2% of former smokers (23 aneurysms) had ruptured aneurysms, and a chi-squared test detected a statisti-cally significant difference across the 3 groups (p = 0.04). The 3 groups did not significantly differ in the initial status of aneurysm occlusion (p = 0.71).
Univariate analysis of aneurysm recurrence
Results of the univariate analysis of aneurysm recurrence are shown in Table 2 . The aneurysm recurrence rate was not significantly associated with smoking: aneurysms in both former smokers (OR 1.00, 95% CI 0.61-1.65; p = 0.99) and current smokers (OR 0.58, 95% CI 0.31-1.09; p = 0.09) had similar odds of recurrence when compared with aneurysm recurrence in patient who were never smokers. Among unruptured aneurysms, the recurrence rate was 23.7% (18 aneurysms) for the aneurysms in patient who were never smokers, 17.1% (13 aneurysms) for those in former smokers, and 23.3% (28 aneurysms) for those in current smokers (p = 0.62). Among ruptured aneurysms, the recurrence rate was 39.5% (17 aneurysms) for the aneurysms in patients who were never smokers, 26.1% (6 aneurysms) for those in former smokers, and 39.7% (19 aneurysms) for those in current smokers (p = 0.60).
The size of the aneurysm diameter was associated with aneurysm recurrence rate; a 1-mm increase in diameter was associated with a significantly (p < 0.001) higher odds in the rate of aneurysm recurrence (OR 1.16, 95% CI 1.10-1.22). Ruptured aneurysms had a significantly higher odds of recurrence (OR 2.15, 95% CI 1.38-3.37; p = 0.001) compared with unruptured aneurysms. Aneurysms with a residual aneurysm (OR 2.42, 95% CI 1.16-5.04; p = 0.02) or a residual neck (OR 1.88, 95% CI 1.17-3.01; p = 0.01) on initial treatment had significantly higher odds of recurrence compared with those with complete occlusion. Table 3 presents the results of univariate analysis of aneurysm retreatment in the 3 groups. Compared with patients who were never smokers, former smokers had similar odds of undergoing retreatment (OR 0.78, 95% CI 0.46-1.35; p = 0.38), and current smokers had significantly lower odds of undergoing retreatment (OR 0.44, 95% CI 0.21-0.91; p = 0.03). Among unruptured aneurysms, the retreatment rate was 19.7% (18 aneurysms) for the aneurysms in patients who were never smokers, 10.5% (8 aneurysms) for those in former smokers, and 15.8% (19 aneurysms) for those in current smokers (p = 0.34). Among ruptured aneurysms, the retreatment rate was 32.6% (14 aneurysms) for the aneurysms in patients who were never smokers, 17.4% (4 aneurysms) for those in former smokers, and 27.4% (20 aneurysms) for those in current smokers (p = 0.49).
Univariate analysis of aneurysm retreatment
The size of the aneurysm diameter was associated with aneurysm retreatment rate; a 1-mm increase in diameter was associated with a significantly (p < 0.001) increased odds of aneurysm retreatment (OR 1.13, 95% CI 1.07-1.19). Ruptured aneurysms had a significantly higher odds of retreatment (OR 2.06, 95% CI 1.25-3.38; p = 0.004) compared with unruptured aneurysms. Aneurysms with a residual aneurysm (OR 1.61, 95% CI 0.70-3.71; p = 0.26) or residual neck (OR 1.58, 95% CI 0.94-2.67; p = 0.09) on initial treatment were not significantly associated with aneurysm retreatment.
Multivariate analysis
The results of multivariate analyses indicating the likelihood of aneurysm recurrence or retreatment among the 3 patient groups and for various patient and aneurysm characteristics are shown in Tables 2 and 3 . When adjusting for A multivariate analysis adjusted for aneurysm rupture status, aneurysm diameter, and aneurysm occlusion indicated that former smokers (OR 0.49, 95% CI 0.23-1.05; p = 0.07) and current smokers (OR 0.82, 95% CI 0.46-1.46; p = 0.50) had odds of retreatment similar to those who were never smokers (Table 3) . A larger aneurysm diameter was significantly associated with aneurysm retreatment (OR 1.14, 95% CI 1.08-1.21; p < 0.001), and ruptured aneurysms had a significantly higher rate of retreatment than unruptured aneurysms (OR 2.37, 95% CI 1.39-4.04; p = 0.001).
Discussion
The results of our study indicate that tobacco smoking is not significantly associated with aneurysm recurrence or retreatment among patients undergoing endovascular coiling for intracranial aneurysms. In both uni-and multivariate analyses of the entire cohort, as well as in a subgroup analysis of unruptured aneurysms, we failed to detect an effect of smoking on the risk for either angiographically confirmed recanalization or retreatment. These findings suggest that smoking status should not be a factor for excluding patients for endovascular treatment of intracranial aneurysms. Similar to what has been observed in previous studies, variables associated with a significantly increased rate of aneurysm recurrence included previous rupture, initial aneurysm occlusion, and an increased aneurysm diameter.
Some studies have shown that cigarette smoking is a risk factor for both intracranial aneurysm formation and recurrence after endovascular coiling. It has been proposed that the pathophysiology of aneurysm formation among cigarette smokers results from a decrease in a1-antitrypsin levels. 4, 5 In a study of 110 patients, Ortiz et al. reported an OR of 4.53 for aneurysm recurrence among cigarette smokers when compared with rates of aneurysm recurrence among nonsmokers. 11 These authors also showed that among patients with SAH, the recurrence rate was positively correlated with SAH severity as measured with the Hunt and Hess scale. We note some important differences between the study by Ortiz and colleagues and the current study. First, the rate of aneurysm recanalization in the Ortiz et al. study was approximately 42%, higher than the 27% recanalization rate observed in our study. Second, we stratified our patients into 3 groups, smokers, former smokers, and never smokers, whereas Ortiz et al. stratified their patient cohort into never/nonsmokers and former/current smokers. This difference in stratification may be important because the effects of smoking on inflammation markedly diminish after smoking ceases, especially in cardiovascular diseases.
1, 3 In a large study of 607,558 adult patients undergoing major surgery, Musallam et al. observed that only current smoking was associated with poor surgical outcomes and that former smokers had rates of poor outcomes similar to those among nonsmokers. 10 By stratifying patients into 3 groups, our study could more directly compare the role of perioperative smoking in influencing angiographically determined outcomes of aneurysm treatment.
Our study also provided information on the relationship between smoking status and aneurysm recurrence requiring retreatment. A better understanding of the risk factors associated with aneurysm retreatment is important because of the additional costs and risks associated with aneurysm retreatment, although we note that aneurysm recurrence not requiring retreatment is generally associated with low morbidity. Although the results in our study indicated no significant association between smoking and aneurysm recurrence, it is still important to counsel all patients, especially intracranial aneurysm patients, about the risks of smoking. Our study has several limitations. The patients in our study were stratified into those who never, currently, or formerly smoked, but we did not further stratify smokers by pack-year because such data were not available. Previous studies have shown that increased pack-years are associated with an increased risk of an SAH. Furthermore, we categorized the patients according to smoking status through a retrospective chart review rather than a questionnaire. Because our study was retrospective, we did not perform a power calculation before data collection. Therefore, we were unable to perform a post hoc power calculation to validate the nonsignificant associations between smoking status and aneurysm recurrence or aneurysm retreatment. Additionally, we did not examine outcomes by the type of coils used in the endovascular treatment. Although the coil type used could be an important factor in the risk of aneurysm recurrence after this treatment, several randomized trials have failed to show a major difference in occlusion rates across different coil types. 14 We did not examine the relationship between the initial degree of occlusion and the recurrence rate. As mentioned above, previous studies have reported that aneurysms that are completely or almost completely occluded have significantly lower recurrence rates than those that are incompletely occluded. The size of the aneurysm neck is another important factor associated with aneurysm recurrence, but we did not include neck size in the analysis. However, this lack of data on neck size was unlikely to play a major role because aneurysms with neck sizes predictive of unfavorable outcomes were usually treated with surgery or with flow diversion rather than with endosaccular coiling.
conclusions
The results of our study show that smoking is not an independent risk factor for aneurysm recurrence and retreatment among patients receiving endovascular treatment for intracranial aneurysms. Aneurysm rupture and a larger diameter were the only significant predictors of recurrence. Nonetheless, patients with intracranial aneurysms should continue to be counseled about the risks of cigarette smoking. 
